Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.

Détails

ID Serval
serval:BIB_AF3D2CCF0321
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
Périodique
Journal of infection and chemotherapy
Auteur⸱e⸱s
Myriam B.D., Sonia Z., Hanene S., Teheni L., Mounir T.
ISSN
1437-7780 (Electronic)
ISSN-L
1341-321X
Statut éditorial
Publié
Date de publication
03/2017
Peer-reviewed
Oui
Volume
23
Numéro
3
Pages
121-130
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
The prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma (HL) is still controversial. In this work we sought to examine the prognostic differences between EBV-positive and -negative HL through a series of 131 cases from Tunisia.
The status of EBV was assessed by EBV-encoded RNA (EBER) in situ hybridization. Results were correlated to patients' characteristics and outcome.
EBV was detected in the malignant cells in 62 of 131 HL cases (47.3%). EBV-positive HL was associated with extreme age classes (≤15 and > 45 years; p = 0.0001), male gender (p = 0.008), mixed cellularity histologic subtype (p = 0.03), and inversely with leukocytosis (white blood cells ≥15000/mm <sup>3</sup> ) (p = 0.004) and bulky mediastinum (mediastinal-thoracic ratio≥ 0.35) (p = 0.0001). On analysis of all patients, no significant difference between survival rates was found between EBV-positive and EBV-negative HL. In contrast, subgroups analysis revealed a negative effect of EBV infection in terms of overall survival in patients with Ann Arbor stages I/II (p = 0.03) and nodular sclerosis HL subgroup (p = 0.01), and in terms of event free survival in patients with mediastinal-thoracic ratio less than 0.35 (p = 0.03).
These results suggest that EBV infection affects the survival of particular subgroups of HL, especially those with early-stage of the disease.
Mots-clé
Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Disease-Free Survival, Epstein-Barr Virus Infections/complications, Epstein-Barr Virus Infections/pathology, Female, Herpesvirus 4, Human/genetics, Hodgkin Disease/mortality, Hodgkin Disease/pathology, Hodgkin Disease/virology, Humans, In Situ Hybridization/methods, Male, Middle Aged, Prognosis, RNA, Viral/genetics, Tunisia, Viral Matrix Proteins/genetics, Young Adult, Epstein–Barr virus, Hodgkin lymphoma, Prognostic
Pubmed
Web of science
Création de la notice
17/10/2023 7:51
Dernière modification de la notice
20/10/2023 6:10
Données d'usage